Question 1

What is Secukinumab used for?

Accepted Answer

Secukinumab (brand name Cosentyx) is a Biologic (IL-17 Inhibitor) indicated for Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis.

Question 2

How does Secukinumab work?

Accepted Answer

Secukinumab works through the following mechanism: Human monoclonal antibody that selectively binds to IL-17A, inhibiting its interaction with the IL-17 receptor to reduce inflammation..

Question 3

What are the most common side effects of Secukinumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Secukinumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Secukinumab the same as Cosentyx?

Accepted Answer

Cosentyx is a brand name for Secukinumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Secukinumab

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations